% | $
Quotes you view appear here for quick access.

ZIOPHARM Oncology, Inc. Message Board

  • rob_cos rob_cos Jan 9, 2013 5:35 PM Flag

    Ph 3 Picasso data possible Late Breaker at ASCO after PR/Conf call at time of data....


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think that this news or data will be leaking out and I mean soon!

      Sentiment: Strong Buy

      • 2 Replies to zahnd9898
      • Management is pushing the deadlines right up to the last moment. This shows supreme confidence on the part of management. I don't think they would jump through all these hoops to present an abstract that shows our Picasso Phase III trial failed. JMO

        Sentiment: Strong Buy

      • They really nailed the ASCO late breaking abstract with the timing of this...look at the guidelines:

        The ASCO Late-Breaking Abstracts Policy allows for the submission of Late-Breaking Abstracts only for randomized phase III trials for which no preliminary data are available at the time of the abstract submission deadline (February 5, 2013), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 1, 2013 (deadline for the final, updated Late-Breaking Abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline.

        Missed the normal abstract deadline by a week, and will get the analysis done a week before the second deadline.

5.55-0.25(-4.31%)Oct 21 4:00 PMEDT